Showing results (41-50 of 94) with videos related to
Sort By:
Pageof 10
Cancer Research|April 3, 2008
A novel lung cancer signature mediates metastatic bone colonization by a dual mechanismSilvestre Vicent, Diego Luis-Ravelo, Iker Antón, et al.Plos One|February 6, 2013
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivoJulia Brun, François-Xavier Dieudonné, Caroline Marty, et al.Nature Communications|March 21, 2014
Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycleFrançois Lamoureux, Marc Baud'huin, Lidia Rodriguez Calleja, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosisAna Patiño-García, Marta Zalacain, Cecilia Folio, et al.Cancer Genomics & Proteomics|March 25, 2008
CDH11 expression is associated with survival in patients with osteosarcomaGo Nakajima, Ana Patino-Garcia, Skjalg Bruheim, et al.American Journal of Respiratory and Critical Care Medicine|June 6, 2019
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to DasatinibIrati Garmendia, María J Pajares, Francisco Hermida-Prado, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled studyMarta Gimeno, Mikel San Julián, Mauricio Cambeiro, et al.Cancer Biomarkers : Section a of Disease Markers|February 3, 2012
Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survivalCecilia Folio, Marta Zalacain, Carolina Zandueta, et al.Cell Research|July 21, 2020
Wnt signaling and Loxl2 promote aggressive osteosarcomaKazuhiko Matsuoka, Latifa Bakiri, Lena I Wolff, et al.Brachytherapy|May 28, 2018
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trialRafael Martínez-Monge, Germán Valtueña Peydró, Mauricio Cambeiro, et al.Pageof 10